These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20332185)

  • 21. Angiotensin II increases expression of alpha1C subunit of L-type calcium channel through a reactive oxygen species and cAMP response element-binding protein-dependent pathway in HL-1 myocytes.
    Tsai CT; Wang DL; Chen WP; Hwang JJ; Hsieh CS; Hsu KL; Tseng CD; Lai LP; Tseng YZ; Chiang FT; Lin JL
    Circ Res; 2007 May; 100(10):1476-85. PubMed ID: 17463319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Angiotensin II-induced endothelin-1 release in cardiac myocytes].
    Villa-Abrille MC; Cingolani HE; Garciarena CD; Ennis IL; Aiello EA
    Medicina (B Aires); 2006; 66(3):229-36. PubMed ID: 16871910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LOX-1 deletion alters signals of myocardial remodeling immediately after ischemia-reperfusion.
    Hu C; Dandapat A; Chen J; Fujita Y; Inoue N; Kawase Y; Jishage K; Suzuki H; Sawamura T; Mehta JL
    Cardiovasc Res; 2007 Nov; 76(2):292-302. PubMed ID: 17707356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes.
    Zhou J; Xu X; Liu JJ; Lin YX; Gao GD
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1191-8. PubMed ID: 17880376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LOX-1 deletion limits cardiac angiogenesis in mice given angiotensin II.
    Wang X; Khaidakov M; Guo Z; Ding Z; He Q; Mehta JL
    Cardiovasc Drugs Ther; 2014 Oct; 28(5):441-6. PubMed ID: 25005756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin IV protects against angiotensin II-induced cardiac injury via AT4 receptor.
    Yang H; Zeng XJ; Wang HX; Zhang LK; Dong XL; Guo S; Du J; Li HH; Tang CS
    Peptides; 2011 Oct; 32(10):2108-15. PubMed ID: 21963909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ets-1 is a critical transcriptional regulator of reactive oxygen species and p47(phox) gene expression in response to angiotensin II.
    Ni W; Zhan Y; He H; Maynard E; Balschi JA; Oettgen P
    Circ Res; 2007 Nov; 101(10):985-94. PubMed ID: 17872466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha.
    Fujita K; Maeda N; Sonoda M; Ohashi K; Hibuse T; Nishizawa H; Nishida M; Hiuge A; Kurata A; Kihara S; Shimomura I; Funahashi T
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):863-70. PubMed ID: 18309113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular dissection of angiotensin II-activated human LOX-1 promoter.
    Chen J; Liu Y; Liu H; Hermonat PL; Mehta JL
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1163-8. PubMed ID: 16484599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serial analysis of gene expression in mouse kidney following angiotensin II administration.
    Schwartz F; Duka A; Triantafyllidi E; Johns C; Duka I; Cui J; Gavras H
    Physiol Genomics; 2003 Dec; 16(1):90-8. PubMed ID: 14570981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) and cardiac fibroblast growth.
    Wang X; Khaidakov M; Ding Z; Mitra S; Lu J; Dai Y; Mehta JL
    Hypertension; 2012 Dec; 60(6):1437-42. PubMed ID: 23045471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IRF3 regulates cardiac fibrosis but not hypertrophy in mice during angiotensin II-induced hypertension.
    Tsushima K; Osawa T; Yanai H; Nakajima A; Takaoka A; Manabe I; Ohba Y; Imai Y; Taniguchi T; Nagai R
    FASEB J; 2011 May; 25(5):1531-43. PubMed ID: 21266535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy.
    Matsui Y; Jia N; Okamoto H; Kon S; Onozuka H; Akino M; Liu L; Morimoto J; Rittling SR; Denhardt D; Kitabatake A; Uede T
    Hypertension; 2004 Jun; 43(6):1195-201. PubMed ID: 15123578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A distinct AMP-activated protein kinase phosphorylation site characterizes cardiac hypertrophy induced by L-thyroxine and angiotensin II.
    Jiang SY; Xu M; Ma XW; Xiao H; Zhang YY
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):919-25. PubMed ID: 20497424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion of soluble epoxide hydrolase attenuates cardiac hypertrophy via down-regulation of cardiac fibroblasts-derived fibroblast growth factor-2.
    Zhang H; Wang T; Zhang K; Liu Y; Huang F; Zhu X; Liu Y; Wang MH; Tang W; Wang J; Huang H
    Crit Care Med; 2014 May; 42(5):e345-54. PubMed ID: 24448199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo.
    Freund C; Schmidt-Ullrich R; Baurand A; Dunger S; Schneider W; Loser P; El-Jamali A; Dietz R; Scheidereit C; Bergmann MW
    Circulation; 2005 May; 111(18):2319-25. PubMed ID: 15870116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpressed connective tissue growth factor in cardiomyocytes attenuates left ventricular remodeling induced by angiotensin II perfusion.
    Zhang Y; Yan H; Guang GC; Deng ZR
    Clin Exp Hypertens; 2017; 39(2):168-174. PubMed ID: 28287886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin.
    Yokoyama C; Aoyama T; Ido T; Kakino A; Shiraki T; Tanaka T; Nishigaki K; Hasegawa A; Fujita Y; Sawamura T; Minatoguchi S
    PLoS One; 2016; 11(5):e0154994. PubMed ID: 27195769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Communication between myocytes and fibroblasts in cardiac remodeling in angiotensin chimeric mice.
    Matsusaka T; Katori H; Inagami T; Fogo A; Ichikawa I
    J Clin Invest; 1999 May; 103(10):1451-8. PubMed ID: 10330427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adaptive and maladaptive remodeling of cardiomyocyte excitation-contraction coupling by angiotensin II.
    Egger M; Domenighetti AA
    Trends Cardiovasc Med; 2010 Apr; 20(3):78-85. PubMed ID: 21130950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.